HIV DART 2022
Los Cabos, Mexico / 4-6 December 2022
Dear Colleagues,
The focus of HIV & Respi DART 2022 is to assemble basic scientists, clinicians, medical professionals, and nurses together to advance our knowledge of the ongoing drug development process in the treatment and cure of HIV and SARS-CoV-2. After we held the 2020 conferences virtually due to the pandemic, we are pleased we have returned to an in-person format at the Hilton in Cabos San Lucas Mexico from December 4-8, 2022.
The DART series conferences highlight emerging challenges facing today’s global community. Antiretroviral drug development against HIV has seen many successes over the past three decades. However, many barriers still remain unresolved. This year, we plan to address advancements in cure strategies, antiretroviral therapy and long-acting formulations. At the same time, the continued difficulties around the SARS-CoV-2 warrants an up-to date, high-quality and multi-faceted platform where the latest developments and cutting-edge discoveries can be shared, discussed and analyzed.
HIV & Respi DART 2022 will focus on topics such as advances in epidemiology, diagnostics, therapeutics, vaccinology, immunity and inflammation, virus/host interactions, enzymology, and new study models in development. Emphasis is placed on sharing the latest clinical data for several small molecules advancing through human trials. Novel drug targets and mechanisms of action will also be heavily explored. Through participation in this back-to-
back conference, delegates will be able to attend invited lectures by world-renowned leaders, participate in our poster receptions, and take advantage of key networking opportunities with peers and key opinion leaders.
Finally, this year we have the pleasure to honor Dr. James W. Curran and Dr. Christian Bréchot with distinguished lecture awards in recognition of their important contributions to the field of HIV and virology research and advocacy over the past several decades.
The in-person format of HIV & Respi DART 2022 will provide a highly invigorating and accessible platform for the global scientific community to engage with their peers and learn about the latest advancements in this arena. We look forward to seeing you this year!
Program co-chair on behalf of the Organizing Committees,
Raymond F. Schinazi, PhD, Hon DSc , FAASLD
Emory University, USA
HIV DART 2022: Organizing Committee
Raymond F. Schinazi
Emory University, United States
Hiroaki Mitsuya
National Center for Global Health and Medicine Japan & NIH, United States
Monique Nijhuis
UMC Utrecht, Netherlands
Michaela Muller-Trutwin
Pasteur Institute France
Savita Pahwa
University of Miami Health System, United States
HIV DART 2022: Scientific Committee
Eddy Arnold- Rutgers University, USA
Henry Chang- University of California Los Angeles, USA
Steve Deeks- University of California, San Francisco, USA
Carlos Del Rio- Emory University, USA
Matthias Götte- University of Alberta, Canada
Vince Marconi- Emory University, USA
Una O’Doherty- University of Pennsylvania, USA
Sarah Palmer- University of Sydney, Australia
Jose Rodriguez- University of Puerto Rico, USA
Michael Saag- University of Alabama at Birmingham, USA
Jonathan Schapiro- Sheba Medical Center, Israel
Nicolas Sluis-Cremer- University of Pittsburgh, USA
Mario Stevenson- University of Miami, USA
Ron Swanstrom- University of North Carolina, USA
HIV DART 2022: Post-meeting information
Feedback survey
We invite all HIV DART 2022 attendees to complete a short feedback survey on this year’s meeting. Your feedback is extremely important to us and will help us improve the program for future years.
CME Accreditation
Emory University is the CME provider for HIV / Respi DART 2022. If you signed up for CME credits during the conference, you will be receiving your accreditation via email in late February 2022.
Certificate of Attendance
Please email us at info@hepdart.com if you would like to receive a certificate of attendance.
HEP DART 2023
Please sign up for our newsletter to receive information about HEP DART 2023.
IHE educational programming would not be possible without the support of our generous partners.
Gold Sponsors
Silver Sponsors
Bronze Sponsors
Contributing Sponsors
PARTNERS
